Skip to content

Author

Victor Gabriel de Medeiros Brito

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Cerebral cryptococcoma in an immunocompetent patient: diagnostic challenge and neoplastic mimicry

Case Presentation: A 54-year-old female patient, previously healthy and immunocompetent, presented with a nodular cutaneous lesion on the upper limb. Histopathological examination and culture of the lesion confirmed infection by Cryptococcus spp. sensitive to fluconazole, and oral therapy was initiated. Complete blood...

Erick Dantas Bernardo, Ingrid Yasmim Farias de Melo, Glenda Suelen Ferreira Monteiro et al. · 0 citations
Open access Oct 2026

Expansive cerebral lesion caused by cryptococcus in an immunocompetent patient: a diagnostic challenge

Case Presentation: A 62-year-old patient, previously healthy and immunocompetent, presented with speech difficulty that began three weeks earlier, characterized by slowed speech and word-finding difficulty, associated with reduced strength in the right hemibody. On neurological examination, the patient showed mild moto...

Marliany Lívia Gomes Soares, Iury Hélder Santos Dantas, Erick Dantas Bernardo et al. · 0 citations
Review Open access Oct 2026

Lipid nanoparticle-mediated gene silencing as a targeted therapeutic strategy for glioblastoma multiforme

Background: Glioblastoma multiforme is one of the most prevalent primary brain neoplasms worldwide and is associated with high mortality rates. This scenario largely results from tumor heterogeneity, limited therapeutic options, and the difficulty of drug penetration into the central nervous system due to the presence...

Victor Gabriel de Medeiros Brito, Daiany de Medeiros Verde, Matheus Emanuel Lima Viturino et al. · 0 citations
Open access Oct 2026

Coexistence between myasthenia gravis and neuromyelitis optica: a case report

In patients with dual diagnosis and complications from chronic steroid use, such as the bilateral cataracts and retinitis seen in this case, the switch to highly specific monoclonal antibodies is essential to minimize systemic toxicity while maintaining strict disease control.

Victor Medeiros Rebouças, Lúcio Fábio de Assis Arruda, Erick Dantas Bernardo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.